
Pharmaceutical firm Lundbeck has filed a lawsuit in the US against Viatris for violating the patent protection of schizophrenia drug Abilify Maintena, Bloomberg News reports.
A total of two lawsuits have been filed alongside Otsuka, which is behind the drug and has exclusively licensed it to Lundbeck.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app